Related Experiment Videos
The role of carrageenan in complement activation.
Summary
Carrageenan inhibits complement activity by preferentially activating the classical pathway, not the alternative pathway. This interaction is key to understanding carrageenan-induced inflammation.
Area of Science:
- Immunology
- Biochemistry
Background:
- Carrageenan is known to inhibit hemolytic complement activity both in vivo and in vitro.
- The precise mechanism of carrageenan's interaction with the complement system remains unclear.
Purpose of the Study:
- To investigate the nature of the interaction between complement and carrageenan.
- To determine which complement pathway(s) carrageenan activates or inhibits.
Main Methods:
- Modified hemolytic complement-fixation tests were used to measure complement consumption in human and rat sera.
- Energy-dispersive X-ray analysis determined the sulfate content of carrageenan.
- Complement-mediated lysis of carrageenan-coated sheep erythrocytes was assessed in the presence of ethylene glycol-bis-(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid.
Main Results:
- Carrageenan consumption of complement was observed for both the classical and alternative pathways, with median effective concentrations ranging from 3-300 µg/ml (classical) and 500-7800 µg/ml (alternative).
- Sulfate content did not correlate with complement consumption levels.
- Carrageenan-coated erythrocytes were lysed by complement, and this lysis was inhibited by a classical pathway inhibitor, confirming carrageenan's preferential activation of the classical pathway.
Conclusions:
- Carrageenan preferentially activates the classical complement pathway.
- Understanding this pathway activation is crucial for elucidating carrageenan-induced inflammatory responses.